West Pharmaceutical Services (NYSE:WST) versus Motus GI (NASDAQ:MOTS) Head-To-Head Contrast

West Pharmaceutical Services (NYSE:WST) and Motus GI (NASDAQ:MOTS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Profitability

This table compares West Pharmaceutical Services and Motus GI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	18.25%	19.17%	14.38%
Motus GI	-3,239.75%	-1,731.08%	-115.99%

Analyst Ratings

This is a breakdown of current recommendations for West Pharmaceutical Services and Motus GI, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0	1	3	0	2.75
Motus GI	0	0	0	0	N/A

West Pharmaceutical Services presently has a consensus target price of $442.75, indicating a potential upside of 54.59%. Given West Pharmaceutical Services’ higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than Motus GI.

Valuation & Earnings

This table compares West Pharmaceutical Services and Motus GI”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$2.88 billion	7.25	$593.40 million	$7.58	37.78
Motus GI	$319,000.00	0.03	-$12.87 million	($15.64)	0.00

West Pharmaceutical Services has higher revenue and earnings than Motus GI. Motus GI is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 0.5% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

West Pharmaceutical Services has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500.

Summary

West Pharmaceutical Services beats Motus GI on 12 of the 13 factors compared between the two stocks.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

About Motus GI

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.